How did ZYME's Q1 2025 EPS forecast compare to past trends?

Zymeworks Inc. (ZYME) anticipated earnings per share (EPS) for Q1 2025 were forecasted at ($0.51) by Leerink Partners, which would reflect a significant decline from the company's historical EPS figures: 1. **Significant Decline**: This ($0.51) EPS projection for Q1 2025 represents a substantial decrease from the company's recent past, where the EPS ranged from a low of ($0.64) in 2017 to a high of $1.90 in 2022. |code|Ticker|Name|Date|Diluted EPS (FY) YoY|Diluted EPS (FY)|market_code| |---|---|---|---|---|---|---| |ZYME|ZYME.O|Zymeworks|2020|6.5274151436031325|-3.58|185| |ZYME|ZYME.O|Zymeworks|2021|-28.770949720670398|-4.61|185| |ZYME|ZYME.O|Zymeworks|2022|141.21475054229933|1.9|185| |ZYME|ZYME.O|Zymeworks|2023|-190.5263157894737|-1.72|185| |ZYME|ZYME.O|Zymeworks|2024|5.813953488372086|-1.62|185| 2. **Improvement from Previous Year**: The forecasted EPS of ($0.51) for Q1 2025 is an improvement compared to the previous year's EPS of ($1.72) for Q1 2024, indicating a potential recovery or stabilization in earnings after a period of significant decline. 3. **Industry and Company Performance**: It's important to note that these forecasts are based on current industry trends and the company's specific circumstances. Zymeworks has faced challenges, including missing revenue estimates in previous quarters, which could impact the accuracy of these forecasts. In conclusion, Zymeworks' Q1 2025 EPS forecast represents a significant decline from the company's historical norms but shows an improvement from the previous year, indicating a complex picture of potential recovery amidst ongoing financial challenges.